bilaterals.org logo
bilaterals.org logo

intellectual property


EU-Japan FTA - draft intellectual property chapter (May 2017)
As leaked by Greenpeace
Time for costly medicine monopolies to go from TPP trade talks
The latest plan to get the controversial trade deal up and running involves freezing some of its controversial rules, including rules for biologic drugs, an expensive class of medicines often used to treat conditions such as cancer and rheumatoid arthritis.
New paper explains TPP’s impact on access to medicines in member countries
As the TPP-11 meet to attempt to revive the TPP without the US, the research findings show how damaging the original medicine proposals would be.
India to oppose anti-generics proposals at RCEP meet
India firm in opposing proposals that could hinder global access to affordable generic drugs
India will not cross red lines on generic drugs in RCEP, but stay vigilant, say officials
Healthcare watchers are calling on India to resist RCEP
Access to affordable stents and other medical devices – Indian Government should reject the bullying tactics of the US based medical device industry
Access to health products is non-negotiable; the Indian Government should reject the bullying tactics of the US based medical device industry.
Six inconvenient truths about NAFTA renegotiations
This article is part of a series about what the renegotiation of the North American Free Trade Agreement means for the knowledge economy in Canada and for the people who turn ideas into innovations within one of the world’s largest free trade zones.
US needs to push range of economic issues with India: Kenneth Juster
The US must push a range of economic issues with India, including intellectual property, standard and non-tariff barriers, President Donald Trump’s nominee to be the next envoy to India has told lawmakers.
Free trade talks with EFTA grouping hit IPR, services wall
Switzerland insists on intellectual property commitments beyond TRIPS.
Canada pushes back against US copyright demands in NAFTA
The United States is using the TPP as a template for the draft IP chapter that it is presenting to its negotiating partners in this round. Canada, however, isn’t down with that.
EU-Mercosur trade agreement would harm user rights and the commons
The EU-Mercosur FTA is expansive, addressing trade in industrial and agricultural goods as well as intellectual property provisions such as copyrights and patents.
Without US, 11 nations in TPP inch closer to a deal
Negotiators met for two days in the Japanese capital, Tokyo, to discuss what parts of the original deal they wished to shelve.
TPP members whittle list of rules to shelve with US gone
Terms on intellectual property protections, state-owned enterprises up for debate.
Music groups push USTR on NAFTA copyright agenda
A coalition of more than 20 music groups are urging U.S. trade negotiators to look beyond U.S. law to forge stronger copyright protections in a new NAFTA.
Lighthizer presses Thailand on AG trade barriers
Lighthizer stressed the need to address longstanding trade barriers, including on U.S. meat and other agriculture exports.
USTR launches review of IP in Thailand after reported improvements on enforcement
“I’d be concerned that USTR is pressuring Thailand to take pro-pharma positions on the RCEP and TPP,” Knowledge Ecology International Executive Director James Love said.
Foreign patent owners can challenge domestic judgments under international investment arbitration
The first ever final award on patents in international investment arbitration by ICSID in the case of Eli Lilly v. Canada has effectively cleared the way for raising future disputes by foreign IPR owners against domestic institutions which can result in stronger and robust IP protection regime.
Canada introduces patent term extensions for pharmaceutical patents
The new regime has been implemented in order to meet Canada’s obligations under the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union
New study looks at IP and the rise of mega-regional agreements
A substantive new study with contributions from a range of leading thinkers in the field of intellectual property rights delves into the history and future of mega-regional trade agreements and the evolution of IP rights.
TPP 11 Sydney meeting vindicates community concerns
TPP 11 negotiators have agreed to suspend controversial clauses on medicine monopolies and some governments want to renegotiate other clauses, vindicating public interest group concerns